New study to track allergic reactions to imaging agent in breast cancer surgery
Knowledge-focused
Not yet recruiting
This study will observe 1500 adults with breast cancer who receive LUMISIGHT during lumpectomy surgery. The goal is to measure how often serious allergic reactions happen within 60 minutes after the injection. The study does not test a new drug but collects safety information on …
Sponsor: Lumicell, Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC